ShopSpell

Handbook of Psoriasis and Psoriatic Arthritis [Paperback]

$76.99     $79.99   4% Off     (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  3319182269
  • ISBN-10:  3319182269
  • ISBN-13:  9783319182261
  • ISBN-13:  9783319182261
  • Publisher:  Adis
  • Publisher:  Adis
  • Pages:  80
  • Pages:  80
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Mar-2016
  • Pub Date:  01-Mar-2016
  • SKU:  3319182269-11-SPRI
  • SKU:  3319182269-11-SPRI
  • Item ID: 101807035
  • List Price: $79.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Nov 01 to Nov 03
  • Notes: Brand New Book. Order Now.

This concise handbook looks at psoriasis and psoriatic arthritis as separate but often related conditions, focusing on a background around the indications, such as disease overview and epidemiology; going on to look at the etiology and immunopathogenesis of each indication; looking at the clinical presentation and diagnosis; before focusing on the current and emerging treatment options, including a brief section on the issues of quality of life and comorbidities associated with these indications. Introduction.- Pathogenesis of psoriasis and psoriatic arthritis.- Clinical presentation of psoriasis and psoriatic arthritis.- Diagnosis and evaluation of psoriasis and psoriatic arthritis.- Treatment of psoriasis.- Treatment of psoriatic arthritis.- Quality of life in psoriasis.

Richard Warren, MBChB, MRCP, PhD, is a Clinical SeniorLecturer and Honorary Consultant Dermatologist. He graduated from Liverpool Universitywith a first class honours degree in Pharmacology and gained his Medicaldegree, with honours, one year later. He was awarded The J Hill Abram prize highest mark in Medicine; and the Reginald Dora Goodrick prize  highest markin Surgery. His work in Dermatology has focused on: pharmacogenetics (formingthe basis of his PhD thesis), the genetic susceptibility to psoriasis and morerecently biological therapies and their use in the treatment of psoriasis. Forhis work into the pharmacogenetics of methotrexate he has received national andinternational awards from the British Association of Dermatologists (BAD) andAmerican Academy of Dermatology. He is widely published in the field ofdermatology with numerous abstracts, papers and book contributions includingThe Lancet, Nature Genetics, and The Journal of Investigative Dermatology. Heis currently the EU Editor in Chief for the journal Dermatology and Therapy. Hehas been an invited plenary speaker at major national and international dermatologymeetings and is a member of The International Plc-

Add Review